Markets › India › NSE › LINCOLN

Lincoln Pharmaceuticals Ltd

NSE:LINCOLNHealthcare

₹535.35−1.88%At closeAt close · Mon 19 Oct · ≈ AED 20.68 · Market cap $115.16M

INR billions	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	YoY
Net income	0.8	1.0	1.0	0.9	1.1	0.9	−19.5%
Depreciation & amortization	0.1	0.1	0.1	0.1	0.1	0.1	+12.4%
Stock-based compensation	0.0	0.0	0.0	0.0	0.0	0.0	—
Change in working capital	0.0	0.0	(0.3)	(0.2)	0.1	0.1	+4.2%
Operating cash flow	0.7	0.8	0.4	0.6	0.9	1.1	+15.0%
Capital expenditure	(0.1)	(0.5)	(0.1)	(0.4)	(0.2)	(0.3)	−32.1%
Acquisitions	0.0	(0.1)	0.0	0.0	0.0	0.0	—
Investing cash flow	(0.6)	(0.8)	(0.4)	(0.6)	(0.8)	(1.0)	−26.2%
Dividends paid	0.0	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	+0.0%
Share buybacks	0.0	0.0	0.0	0.0	0.0	0.0	—
Debt issued / repaid	(0.0)	0.0	(0.0)	(0.0)	(0.0)	0.0	+543.4%
Financing cash flow	(0.1)	(0.0)	(0.0)	(0.1)	(0.1)	0.0	+112.8%
Free cash flow	0.6	0.3	0.2	0.2	0.7	0.8	+10.5%
Net change in cash	(0.0)	(0.0)	(0.0)	0.0	0.1	0.2	+149.0%